CUAMC
QNCX icon

China Universal Asset Management Company’s Quince Therapeutics QNCX Stock Holding History

China Universal Asset Management Company’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2
Closed – – 446
2022
Q3 		$0 Buy
+2
New +$762 ﹤0.01% 454

Other funds holding QNCX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

China Universal Asset Management Company's QNCX Position: Q4 2022 in Review

China Universal Asset Management Company sold out of Quince Therapeutics (QNCX) in Q4 2022, closing a stake of 2 shares.

China Universal Asset Management Company first reported a position in QNCX in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 48 funds tracked by Wall St. Rank hold QNCX as of Q4 2022.

  • China Universal Asset Management Company reported no remaining Quince Therapeutics position as of Q4 2022 after selling out during the quarter.
  • China Universal Asset Management Company sold 2 Quince Therapeutics shares in Q4 2022.
  • China Universal Asset Management Company first reported a position in Quince Therapeutics in Q3 2022 and held it in 1 quarter.
  • China Universal Asset Management Company's Quince Therapeutics position peaked at $0 in Q3 2022.
  • 48 funds tracked by Wall St. Rank held Quince Therapeutics as of Q4 2022.

Based on China Universal Asset Management Company's 13F filing for Q4 2022, filed 31 Jan 2023.